FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

387442005: Simeticone (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1481533017 Simethicone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1492085013 Activated methylpolysiloxane en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1492086014 Activated dimethicone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2621392012 Simeticone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3485613019 Simeticone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3713877014 Activated dimeticone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
49341000195118 simeticone it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
840291000172117 siméticone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
63481000195113 Simeticon de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Simeticone Is a agent antiflatulent false Inferred relationship Some
Simeticone Is a Silicone false Inferred relationship Some
Simeticone This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Dimeticone (substance) false Inferred relationship Some
Simeticone Is a Silicone oil false Inferred relationship Some
Simeticone Is a Surfactant (substance) false Inferred relationship Some
Simeticone This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Surfactant (disposition) true Inferred relationship Some
Simeticone Is a Dimeticone (substance) true Inferred relationship Some
Simeticone Is a Silicon dioxide true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Dimethicone adverse reaction Causative agent (attribute) False Simeticone Inferred relationship Some
Allergy to dimeticone Causative agent (attribute) False Simeticone Inferred relationship Some
Product containing precisely simeticone 40 milligram/1 milliliter conventional release oral suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Simeticone Inferred relationship Some
Dimethicone cream BPC The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Simeticone Inferred relationship Some
Simeticone 100 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Simeticone Inferred relationship Some
Product containing precisely simeticone 8.4 milligram/1 milliliter conventional release oral drops (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Simeticone Inferred relationship Some
Simethicone 200mg/0.8m The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Simeticone Inferred relationship Some
Product containing simeticone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Simeticone Inferred relationship Some 1
Dimeticone 66.7mg/ml oral drops sugar free The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Simeticone Inferred relationship Some
Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Simeticone Inferred relationship Some
Loperamide hydrochloride+simethicone The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Simeticone Inferred relationship Some
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Simeticone Inferred relationship Some
Simethicone coated cellulose suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Simeticone Inferred relationship Some
Simethicone coated cellulose 7.5mg/mL oral suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Simeticone Inferred relationship Some
Loperamide hydrochloride 2 mg and simeticone 125 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Simeticone Inferred relationship Some
Product containing magaldrate and simeticone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Simeticone Inferred relationship Some 2
Product containing aluminium hydroxide and magnesium hydroxide and simeticone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Simeticone Inferred relationship Some 3
Product containing hydrotalcite and simeticone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Simeticone Inferred relationship Some 1
Product containing calcium carbonate and simeticone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Simeticone Inferred relationship Some 2
Product containing aluminium hydroxide and simeticone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Simeticone Inferred relationship Some 2
Product containing dimeticone and zinc oxide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Simeticone Inferred relationship Some
Simethicone + hydrotalcite 125mg/500mg oral suspension sugar free The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Simeticone Inferred relationship Some
Product containing pipenzolate and simeticone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Simeticone Inferred relationship Some 2
Product containing simeticone and sodium bicarbonate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Simeticone Inferred relationship Some 2
Product containing loperamide and simeticone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Simeticone Inferred relationship Some 2
Aluminum hydroxide + dimethicone The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Simeticone Inferred relationship Some
Benzalkonium chloride 1 mg/g and dimeticone 220 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Simeticone Inferred relationship Some
Simeticone 100 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Simeticone Inferred relationship Some 1
Simeticone 100 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Simeticone Inferred relationship Some 1
Loperamide hydrochloride 2 mg and simeticone 125 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Simeticone Inferred relationship Some 1
Loperamide hydrochloride 2 mg and simeticone 125 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Simeticone Inferred relationship Some 1
Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Simeticone Inferred relationship Some 1
Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Simeticone Inferred relationship Some 1
Loperamide hydrochloride 2 mg and simeticone 125 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Simeticone Inferred relationship Some 2
Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Simeticone Inferred relationship Some 3
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Simeticone Inferred relationship Some 2
Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Simeticone Inferred relationship Some 3
Simeticone 100 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Simeticone Inferred relationship Some 1
Simeticone-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Simeticone Inferred relationship Some 1
Product containing dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Simeticone Inferred relationship Some 3
Loperamide hydrochloride 2 mg and simeticone 125 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Simeticone Inferred relationship Some 2
Product containing dehydrocholic acid and pancreatin and simeticone The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Simeticone Inferred relationship Some 3
Product containing loperamide and simeticone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Simeticone Inferred relationship Some 2
Product containing precisely simeticone 40 milligram/1 milliliter conventional release oral suspension (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Simeticone Inferred relationship Some 1
Product containing precisely simeticone 40 milligram/1 milliliter conventional release oral suspension (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Simeticone Inferred relationship Some 1
Product containing precisely simeticone 66.7 milligram/1 milliliter conventional release oral drops (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Simeticone Inferred relationship Some 1
Product containing precisely simeticone 66.7 milligram/1 milliliter conventional release oral drops (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Simeticone Inferred relationship Some 1
Product containing precisely simeticone 8.4 milligram/1 milliliter conventional release oral drops (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Simeticone Inferred relationship Some 1
Product containing precisely simeticone 8.4 milligram/1 milliliter conventional release oral drops (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Simeticone Inferred relationship Some 1
Product containing only aluminium hydroxide and magnesium hydroxide and simeticone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Simeticone Inferred relationship Some 3
Product containing only aluminium hydroxide and simeticone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Simeticone Inferred relationship Some 2
Calcium carbonate and simeticone only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Simeticone Inferred relationship Some 2
Product containing only dehydrocholic acid and pancreatin and simeticone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Simeticone Inferred relationship Some 3
Loperamide and simeticone only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Simeticone Inferred relationship Some 2
Hydrotalcite and simeticone only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Simeticone Inferred relationship Some 1
Magaldrate and simeticone only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Simeticone Inferred relationship Some 2
Pipenzolate and simeticone only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Simeticone Inferred relationship Some 2
Simeticone only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Simeticone Inferred relationship Some 1
Simeticone and sodium bicarbonate only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Simeticone Inferred relationship Some 2
Loperamide and simeticone only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Simeticone Inferred relationship Some 2
Simeticone only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Simeticone Inferred relationship Some 1
Product containing only dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Simeticone Inferred relationship Some 3
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Simeticone Inferred relationship Some 1
Loperamide hydrochloride 2 mg and simeticone 125 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Simeticone Inferred relationship Some 1
Product containing only dicycloverine and simeticone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Simeticone Inferred relationship Some 2
Product containing dicycloverine and simeticone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Simeticone Inferred relationship Some 2
Product containing dicycloverine and simeticone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Simeticone Inferred relationship Some 2
Product containing only dicycloverine and simeticone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Simeticone Inferred relationship Some 2
Product containing precisely dicycloverine hydrochloride 10 milligram/1 milliliter and simeticone 40 milligram/1 milliliter conventional release oral drops (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Simeticone Inferred relationship Some 2
Product containing precisely dicycloverine hydrochloride 10 milligram/1 milliliter and simeticone 40 milligram/1 milliliter conventional release oral drops (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Simeticone Inferred relationship Some 2
Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Simeticone Inferred relationship Some 3
Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Simeticone Inferred relationship Some 3
Aluminium hydroxide and magnesium hydroxide and simeticone only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Simeticone Inferred relationship Some 3
Aluminium hydroxide- and magnesium hydroxide- and simeticone-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Simeticone Inferred relationship Some 3

This concept is not in any reference sets

Back to Start